Xvivo Perfusion Correlations
| XVIPF Stock | USD 41.23 0.77 1.83% |
The current 90-days correlation between Xvivo Perfusion AB and Glaukos Corp is -0.05 (i.e., Good diversification). The correlation of Xvivo Perfusion is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Xvivo Perfusion Correlation With Market
Modest diversification
The correlation between Xvivo Perfusion AB and DJI is 0.21 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Xvivo Perfusion AB and DJI in the same portfolio, assuming nothing else is changed.
Xvivo |
The ability to find closely correlated positions to Xvivo Perfusion could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Xvivo Perfusion when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Xvivo Perfusion - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Xvivo Perfusion AB to buy it.
Moving together with Xvivo Pink Sheet
Moving against Xvivo Pink Sheet
| 0.75 | MRVL | Marvell Technology Earnings Call This Week | PairCorr |
| 0.71 | ALAB | Astera Labs, Common Tech Boost | PairCorr |
| 0.71 | SCHW | Charles Schwab Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.7 | GM | General Motors | PairCorr |
| 0.67 | GVA | Granite Construction | PairCorr |
| 0.66 | NVDA | NVIDIA | PairCorr |
| 0.66 | DECK | Deckers Outdoor | PairCorr |
| 0.63 | ADSK | Autodesk | PairCorr |
| 0.62 | DXYZ | Destiny Tech100 Trending | PairCorr |
| 0.61 | CRWD | Crowdstrike Holdings Earnings Call This Week | PairCorr |
| 0.61 | STLD | Steel Dynamics Fiscal Year End 28th of January 2025 | PairCorr |
| 0.58 | ZM | Zoom Video Communications Earnings Call This Week | PairCorr |
| 0.55 | SNOW | Snowflake Trending | PairCorr |
| 0.55 | RCAT | Red Cat Holdings Trending | PairCorr |
| 0.53 | DXCM | DexCom Inc | PairCorr |
| 0.51 | SYK | Stryker | PairCorr |
| 0.47 | BSX | Boston Scientific Corp | PairCorr |
| 0.41 | ABT | Abbott Laboratories Fiscal Year End 22nd of January 2025 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Xvivo Pink Sheet performing well and Xvivo Perfusion Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Xvivo Perfusion's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| NUVA | 1.23 | (0.08) | 0.00 | (0.05) | 0.00 | 3.31 | 7.19 | |||
| GKOS | 1.56 | (0.03) | 0.02 | 0.08 | 1.67 | 3.30 | 13.23 | |||
| CNMD | 1.82 | 0.00 | 0.00 | 0.10 | 2.28 | 4.57 | 11.47 | |||
| LIVN | 1.20 | 0.07 | 0.04 | 0.17 | 1.42 | 3.73 | 8.68 | |||
| MASI | 1.60 | 0.36 | 0.27 | 0.37 | 1.10 | 4.84 | 14.35 | |||
| AZYO | 3.96 | 0.64 | 0.13 | 3.54 | 3.84 | 8.44 | 30.62 | |||
| ESTA | 3.31 | (0.14) | (0.01) | 0.02 | 4.15 | 8.20 | 22.26 | |||
| CVRX | 4.12 | 0.98 | 0.22 | 1.72 | 3.55 | 12.31 | 41.08 | |||
| AXGN | 2.25 | (0.05) | (0.01) | 0.06 | 3.80 | 4.73 | 21.60 | |||
| SRGA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Xvivo Perfusion without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
Xvivo Perfusion Corporate Management
| Jaya Tiwari | VP Affairs | Profile | |
| Magnus Nilsson | Advisor | Profile | |
| Katrin Gisselfalt | Global Director | Profile | |
| Charlotte Walldal | Global director | Profile | |
| Lena BSc | Chief Officer | Profile | |
| Andreas MD | Chief Officer | Profile | |
| Johan Holmstrom | Chief Officer | Profile |